课题基金 / 基金详情

Mechanisms in RiPP Natural Product Biosynthesis

Mechanisms in RiPP Natural Product Biosynthesis
RiPP 天然产物生物合成机制
批准号:
RGPIN-2017-04485
负责人:
Thibodeaux, Christopher
金额:
$1.97万
依托单位:
依托单位国家:
加拿大
项目类别:
Discovery Grants Program - Individual
财政年份:
2020
资助国家:
加拿大
项目状态:
已结题
起止时间:
2020-01-01 至 2021-12-31

项目摘要

项目成果

Thibodeaux, Christopher的其他基金

相似基金

相关文献

中文摘要
翻译
天然产品是由具有多种生物、生态和人类学功能的生物有机体制成的化合物,最主要的是作为治疗各种人类疾病的药物。事实上,美国食品和药物管理局(FDA)批准的所有人类使用的药物中,大多数要么是天然产品,要么是天然产品的合成衍生品,这清楚地突显了这些分子对21世纪人类生活质量的重要性。然而,近年来,由于广泛出现的抗菌素耐药性,许多传统上用于治疗人类细菌感染的天然产品已经失去了效力。鉴于这一令人望而生畏的威胁,迫切需要重新努力发现和开发新的抗微生物天然产品。拟议的研究计划寻求通过几个不同但具有凝聚力的研究方向来解决这一日益严重的危机,这些方向旨在阐明构成天然产品的酶的机械原理。最初的研究将集中在开发几种新兴的生物物理方法,以从独特的角度表征生物合成酶。这些研究将提供对是什么使生物合成酶能够发挥其功能的分子机制的理解,并将为潜在地为合成目的而操纵这些功能提供洞察力。此外,该计划将识别和表征具有不寻常结构的分子和具有不寻常功能的酶,分别作为识别新的抗菌化合物的潜在途径和化合物结构修饰的新工具。总而言之,理解 天然产物在分子机制水平上的生物合成提供了一种 指导新天然产物定性的关键基础,理性的 对自然界中不存在的结构进行工程,并有针对性地生产感兴趣的分子。因此,拟议的研究计划预计将极大地有利于正在进行的抗击抗药性人类病原体的斗争-这一努力对加拿大人民和世界各地的人民都具有极其重要的意义。
英文摘要
Natural products are chemical compounds made by living organisms that serve numerous biological, ecological, and anthropological functions most notably as medicines to treat a variety of human illnesses. Indeed, the majority of all drugs approved for human use by the US Food and Drug Administration are either natural products or are synthetic derivatives of natural products, clearly underscoring the importance of these molecules to the quality of human life in the 21st century. In recent years, however, many of the natural products that have been traditionally used to treat human bacterial infections have lost their effectiveness due to the widespread emergence of antimicrobial resistance. In light of this daunting threat, renewed efforts in discovering and developing novel antimicrobial natural products are urgently needed. The proposed research program seeks to address this growing crisis through several distinct, but cohesive research directions that aim to illuminate the mechanistic principles of the enzymes that construct natural products. Initial studies will be focused on developing several emerging biophysical methods to characterize biosynthetic enzymes from unique perspectives. These studies will provide a molecular mechanistic understanding of what enables biosynthetic enzymes to perform their functions, and will provide insights into how those functions may potentially be manipulated for synthetic purposes. In addition, the program will identify and characterize molecules with unusual structures and enzymes with unusual functions, as potential avenues for identifying new antimicrobial compounds and new tools for the structural modification of compounds, respectively. Altogether, understanding natural product biosynthesis on a molecular mechanistic level provides a critical foundation for guiding the characterization of new natural products, for the rational engineering of structures that do not exist in nature, a-nd for the targeted production of molecules of interest. As such, the proposed research program is expected to greatly benefit the ongoing and mounting struggle to combat drug resistant human pathogens - an endeavor of immense importance to the people of Canada and across the world.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Mechanisms in RiPP Natural Product Biosynthesis
  • 批准号:
    RGPIN-2017-04485
  • 项目类别:
    Discovery Grants Program - Individual
  • 资助金额:
    $1.97万
  • 财政年份:
    2022
  • 负责人:
    Thibodeaux, Christopher
  • 依托单位:
Mechanisms in RiPP Natural Product Biosynthesis
  • 批准号:
    RGPIN-2017-04485
  • 项目类别:
    Discovery Grants Program - Individual
  • 资助金额:
    $1.97万
  • 财政年份:
    2021
  • 负责人:
    Thibodeaux, Christopher
  • 依托单位:
Mechanisms in RiPP Natural Product Biosynthesis
  • 批准号:
    RGPIN-2017-04485
  • 项目类别:
    Discovery Grants Program - Individual
  • 资助金额:
    $1.97万
  • 财政年份:
    2019
  • 负责人:
    Thibodeaux, Christopher
  • 依托单位:
Mechanisms in RiPP Natural Product Biosynthesis
  • 批准号:
    RGPIN-2017-04485
  • 项目类别:
    Discovery Grants Program - Individual
  • 资助金额:
    $1.97万
  • 财政年份:
    2018
  • 负责人:
    Thibodeaux, Christopher
  • 依托单位:
国内基金
海外基金
识别青枯菌Ⅲ型效应子RipP1的植物抗病蛋白鉴定及机制解析
  • 批准号:
    32372483
  • 项目类别:
    面上项目
  • 资助金额:
    50.00万元
  • 批准年份:
    2023
  • 负责人:
    张美祥
  • 依托单位:
青枯菌效应蛋白RipP1诱导茄科植物抗病反应的分子机理
  • 批准号:
    31701752
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    23.0万元
  • 批准年份:
    2017
  • 负责人:
    卓涛
  • 依托单位: